Curt LaBelle

Curt LaBelle

President bij
Global Health Investment Fund
55 jaar
Health Technology
Finance
Health Services

Profiel

Curt H.
LaBelle
is currently Chairman-Steering Committee at Serum Institute of India Pvt Ltd. since 2017.
Director at Vedanta Biosciences, Inc. since 2023.
Director at KeepYourSight Foundation, Ophirex, Inc., Revelation Biosciences Sub, Inc. since 2021, CXL Ophthalmics LLC since 2022, Atticus Medical Pty Ltd. since 2015, IanTech, Inc. since 2015, and Adjuvant Capital LP.
Venture Partner.
President & Managing Partner at Global Health Investment Fund since 2015.
Board Member at Maternal Newborn Health Innovations PBC since 2022.
Managing Partner at AXA IM Alts since 2022.
Former roles include Chairman at NuVasive Clinical Services Monitoring, Inc. (2008–2011), SafeOp Surgical, Inc. (2011–2015), Exagen, Inc. (2009–2015), and Alydia Health, Inc. (2018–2021).
Director at KAI Pharmaceuticals, Inc. (2006–2012), Sirion Therapeutics, Inc. (2006–2008), Atomo Diagnostics Ltd. (2016–2023), Hyperion DeFi, Inc. (2015–2022), and Revelation Biosciences, Inc. (2021–2023).
Partner & Managing Director at Tullis Health Investors, Inc. (2010–2015).
Managing Director at Global Health Investment Advisors LLC (2008–2015).
Vice President at Investor Growth Capital LLC (2005–2008) and Patricia Industries AB (2005–2007).
Senior Associate at Tullis Health Investors, Inc. (2002–2005).
Director at Vidacare Corp., Coherex Medical, Inc., Endoscopic Technologies, Inc., TransMolecular, Inc.Education includes a doctorate and an MBA from The Trustees of Columbia University in The City of New York and Columbia Business School, both conferred in 1999, and an undergraduate degree from Brigham Young University in 1994.

Actieve functies van Curt LaBelle

BedrijvenFunctieBegin
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-01-2021
Private Equity Investor -
Atticus Medical Pty Ltd.
Directeur/Bestuurslid 01-09-2015
Directeur/Bestuurslid -
Private Equity Investor 01-06-2015
Private Equity Investor 01-06-2017
Directeur/Bestuurslid 01-07-2022
Directeur/Bestuurslid 01-10-2022
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Eerdere bekende functies van Curt LaBelle

BedrijvenFunctieEinde
░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Curt LaBelle in detail bekijken

Opleiding van Curt LaBelle

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

95

Eerstegraads connecties

31

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit31

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Investor Growth Capital LLC

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Finance

Consumer Services

Finance

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Services

Health Technology

Atticus Medical Pty Ltd.

Health Services

  1. Beurs
  2. Insiders
  3. Curt LaBelle
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU